Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

308 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adapting clinical paradigms to the challenges of cancer clonal evolution.
Murugaesu N, Chew SK, Swanton C. Murugaesu N, et al. Among authors: swanton c. Am J Pathol. 2013 Jun;182(6):1962-71. doi: 10.1016/j.ajpath.2013.02.026. Am J Pathol. 2013. PMID: 23708210 Review.
Chromosomal instability, colorectal cancer and taxane resistance.
Swanton C, Tomlinson I, Downward J. Swanton C, et al. Cell Cycle. 2006 Apr;5(8):818-23. doi: 10.4161/cc.5.8.2682. Epub 2006 Apr 17. Cell Cycle. 2006. PMID: 16628000 Review.
Unraveling the complexity of endocrine resistance in breast cancer by functional genomics.
Swanton C, Downward J. Swanton C, et al. Cancer Cell. 2008 Feb;13(2):83-5. doi: 10.1016/j.ccr.2008.01.021. Cancer Cell. 2008. PMID: 18242507
Chromosomal instability determines taxane response.
Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, Hardcastle T, Lee A, Roy R, East P, Kschischo M, Endesfelder D, Wylie P, Kim SN, Chen JG, Howell M, Ried T, Habermann JK, Auer G, Brenton JD, Szallasi Z, Downward J. Swanton C, et al. Proc Natl Acad Sci U S A. 2009 May 26;106(21):8671-6. doi: 10.1073/pnas.0811835106. Epub 2009 May 19. Proc Natl Acad Sci U S A. 2009. PMID: 19458043 Free PMC article.
RNAi-mediated functional analysis of pathways influencing cancer cell drug resistance.
Lee AJ, Kolesnick R, Swanton C. Lee AJ, et al. Among authors: swanton c. Expert Rev Mol Med. 2009 May 21;11:e15. doi: 10.1017/S1462399409001070. Expert Rev Mol Med. 2009. PMID: 19467173 Review.
Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy.
McClelland SE, Burrell RA, Swanton C. McClelland SE, et al. Among authors: swanton c. Cell Cycle. 2009 Oct 15;8(20):3262-6. doi: 10.4161/cc.8.20.9690. Epub 2009 Oct 31. Cell Cycle. 2009. PMID: 19806022 Review.
Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interference.
Tan DS, Gerlinger M, Teh BT, Swanton C. Tan DS, et al. Among authors: swanton c. Eur J Cancer. 2010 Aug;46(12):2166-77. doi: 10.1016/j.ejca.2010.03.019. Epub 2010 Apr 21. Eur J Cancer. 2010. PMID: 20413300 Review.
Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer.
Burrell RA, Juul N, Johnston SR, Reis-Filho JS, Szallasi Z, Swanton C. Burrell RA, et al. Among authors: swanton c. J Cell Biochem. 2010 Nov 1;111(4):782-90. doi: 10.1002/jcb.22781. J Cell Biochem. 2010. PMID: 20665662 Review.
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets.
Swanton C, Larkin JM, Gerlinger M, Eklund AC, Howell M, Stamp G, Downward J, Gore M, Futreal PA, Escudier B, Andre F, Albiges L, Beuselinck B, Oudard S, Hoffmann J, Gyorffy B, Torrance CJ, Boehme KA, Volkmer H, Toschi L, Nicke B, Beck M, Szallasi Z. Swanton C, et al. Genome Med. 2010 Aug 11;2(8):53. doi: 10.1186/gm174. Genome Med. 2010. PMID: 20701793 Free PMC article.
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.
Gerlinger M, Swanton C. Gerlinger M, et al. Among authors: swanton c. Br J Cancer. 2010 Oct 12;103(8):1139-43. doi: 10.1038/sj.bjc.6605912. Epub 2010 Sep 28. Br J Cancer. 2010. PMID: 20877357 Free PMC article. Review.
308 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page